Cannabis in the United States
The use, sale, and possession of all forms of cannabis in the United States is illegal under federal law. As a Schedule I drug under the federal Controlled Substances Act of 1970, cannabis (legal term marijuana) is considered to have "no accepted medical use" and have a high potential for abuse and physical or psychological dependence. Cannabis use is illegal for any reason, with the exception of FDA-approved research programs. However, individual states have enacted legislation permitting exemptions for various uses, mainly for medical and industrial use.
Cannabis for industrial uses (hemp) was made illegal to grow without a permit under the Controlled Substances Act because of its relation to cannabis as a drug, and any imported products must adhere to a zero tolerance policy. The Agricultural Act of 2014 allows for universities and state-level departments of agriculture to cultivate cannabis for research into its industrial potential.
As a psychoactive drug, cannabis continues to find extensive favor among recreational and medical users in the United States. As of 2018, nine states, the District of Columbia, and the Northern Mariana Islands have legalized recreational use of cannabis, while 31 states, Guam, Puerto Rico, and D.C. have legalized medical use of the drug. Multiple efforts to reschedule cannabis under the Controlled Substances Act have failed, and the United States Supreme Court has ruled in United States v. Oakland Cannabis Buyers' Cooperative (2001) and Gonzales v. Raich (2005) that the federal government has a right to regulate and criminalize cannabis, whether medical or recreational. As a result, cannabis dispensaries are licensed by each state; these businesses sell cannabis products that have not been approved by the U.S. Food and Drug Administration, nor are they legally registered with the federal government to sell controlled substances. Although cannabis has not been approved, the FDA recognizes the potential benefits and has approved two drugs that contain components of marijuana.
The ability of states to implement cannabis legalization policies was weakened after US Attorney General Jeff Sessions rescinded the Cole Memorandum on January 4, 2018 and issued a new memo instructing US Attorneys to enforce federal law related to marijuana. The Cole memo, issued by former Deputy Attorney General James Cole in 2013, urged federal prosecutors to refrain from targeting state-legal marijuana operations. Regarding the medical use of cannabis, the Rohrabacher–Farr amendment still remains in effect to protect state-legal medical cannabis activities from enforcement of federal law.
Roger Roffman, a professor of social work at the University of Washington, asserted in July 2013 that "approximately 3.6 million Americans are daily or near daily users." Peter Reuter, a professor at the School of Public Policy and the Department of Criminology at the University of Maryland, College Park, said that "experimenting with marijuana has long been a normal part of growing up in the U.S.; about half of the population born since 1960 has tried the drug by age 21." A World Health Organization survey found that the United States is the world’s leading per capita marijuana consumer. The 2007 National Survey on Drug Use & Health prepared by the U.S. Department of Health and Human Services indicated that 14.4 million U.S. citizens over the age of 12 had used marijuana within a month. The 2008 survey found that 35 million Americans were willing to tell government representatives that they had used marijuana in the past year.
According to the 2001 National Survey on Drug Use and Health by the Substance Abuse and Mental Health Services Administration, a branch of the U.S. Department of Health and Human Services, 41.9% (more than 2 in 5) of all Americans 12 or older have used cannabis at some point in their lives, while 11.5% (about 1 in 9) reported using it "this year."
Medical use is a common reason why people use marijuana. According to the National Institute on Drug Abuse, "The term medical marijuana refers to using the whole unprocessed marijuana plant or its basic extracts to treat a disease or symptom." However, the U.S Food and Drug Administration (FDA) has not officially approved marijuana as a medicine.
Under federal law, it is illegal to possess, use, buy, sell, or cultivate marijuana in all United States jurisdictions, since the Controlled Substances Act of 1970 classifies marijuana as a Schedule I drug, claiming it has a high potential for abuse and has no acceptable medical use. Despite this federal prohibition, some state and local governments have established laws attempting to decriminalize cannabis, which has reduced the number of "simple possession" offenders sent to jail, since federal enforcement agents rarely target individuals directly for such relatively minor offenses. Other state and local governments ask law enforcement agencies to limit enforcement of drug laws with respect to cannabis. However, under the Supremacy Clause of the United States Constitution, federal law preempts conflicting state and local laws. In most cases, the absence of a state law does not present a preemption conflict with a federal law.
The federal government has criminalized marijuana under the Interstate Commerce Clause, and the application of these laws to intrastate commerce were addressed squarely by the United States Supreme Court in Gonzales v. Raich, 352 F. 3d 1222 in 2005.
In January 2009, President Barack Obama's transition team organized a poll to clarify some of the top issues the American public wants to have his administration look into, and two of the top ten ideas were to legalize the use of cannabis. In July 2009, Gil Kerlikowske, Director of the Office of National Drug Control Policy, clarified the federal government's position when he stated that "marijuana is dangerous and has no medicinal benefit" and that "legalization is not in the president's vocabulary, and it's not in mine." However, a January 2010 settlement between the U.S. Drug Enforcement Administration and the Wo/Men's Alliance for Medical Marijuana (WAMM) provided an example confirming the administration policy as communicated by Attorney General Eric Holder, as WAMM reached an agreement that allowed them to re-open after being shut down by the federal government in 2002.
Following the 2012 presidential election, the Office of National Drug Control Policy under the Obama administration stated that it "steadfastly opposes legalization of marijuana and other drugs because legalization would increase the availability and use of illicit drugs, and pose significant health and safety risks". In February 2014, the administration issued guidelines to banks for conducting transactions with legal marijuana sellers so these new businesses can stash away savings, make payroll, and pay taxes like any other enterprise. However, marijuana businesses still lack access to banks and credit unions due to Federal Reserve regulations.
On August 29, 2013, the Justice Department adopted a new policy (known as the Cole memo) regarding the enforcement of federal law in states that have legalized non-medical cannabis. The policy specified that commercial distribution of cannabis would be generally tolerated, except in certain circumstances, such as if violence or firearms are involved, the proceeds go to gangs and cartels, or if the cannabis is distributed to states where it is illegal.
On December 11, 2014, the Department of Justice told U.S. attorneys to allow Native American tribes on reservations to grow and sell marijuana, even in states where it is illegal. The policy will be implemented on a case-by-case basis and tribes must still follow federal guidelines.
On May 30, 2014, the United States House of Representatives passed the Rohrabacher–Farr amendment, prohibiting the Justice Department from spending funds to interfere with the implementation of state medical marijuana laws. The amendment became law in December 2014, and must be renewed each year in order to remain in effect.
On March 10, 2015, U.S. Senators Rand Paul, Kirsten Gillibrand, and Cory Booker introduced the Compassionate Access, Research Expansion and Respect States Act or CARERS Act. The bipartisan bill would move cannabis from Schedule I to Schedule II of the Controlled Substances Act. This would allow states with medical cannabis laws to legally prescribe it, and allow for much easier research into its medical efficacy. The bill would also allow grow sites besides the University of Mississippi, which has long been the sole supplier of cannabis for academic research, to supply cannabis for study.
The Food and Drug Administration has approved two synthetic cannabis drugs for treating cancer and other medical issues. The federal government of the United States continues to argue that smoked cannabis has no recognized medical purpose (pointing to a definition of "medical purpose" published by the DEA, not the Food and Drug Administration, the National Institutes of Health, the Centers for Disease Control, or the office of the U.S. Surgeon General and the U.S. Public Health Service). Many officials point to the difficulty of regulating dosage of cannabis (a problem for treatment as well as research), despite the availability (in Canada and the United Kingdom) of dosage-controlled Sativex. The United States has also pressured other governments (especially Canada and Mexico, with which it shares borders) to retain restrictions on marijuana.
In 1973 Oregon became the first state to decriminalize cannabis, and in 2012 Colorado and Washington became the first states to legalize recreational use. As of January 2018, nine states (Alaska, California, Colorado, Maine, Massachusetts, Nevada, Oregon, Vermont, and Washington), the District of Columbia, and the Northern Mariana Islands have legalized the recreational use of cannabis, with all but Vermont and D.C. permitting its commercial sale. Another 13 states (plus the U.S. Virgin Islands) are considered to have decriminalized cannabis.
In 1996, California became the first state to legalize the medical use of cannabis when voters approved Proposition 215. As of June 2018, thirty-one states plus Guam, Puerto Rico, and the District of Columbia have legalized the medical use of cannabis. Fifteen other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis.
State and territory laws
- Cannabis in Alabama
- Cannabis in Alaska
- Cannabis in Arizona
- Cannabis in Arkansas
- Cannabis in California
- Cannabis in Colorado
- Cannabis in Connecticut
- Cannabis in Delaware
- Cannabis in Florida
- Cannabis in Georgia
- Cannabis in Hawaii
- Cannabis in Idaho
- Cannabis in Illinois
- Cannabis in Indiana
- Cannabis in Iowa
- Cannabis in Kansas
- Cannabis in Kentucky
- Cannabis in Louisiana
- Cannabis in Maine
- Cannabis in Maryland
- Cannabis in Massachusetts
- Cannabis in Michigan
- Cannabis in Minnesota
- Cannabis in Mississippi
- Cannabis in Missouri
- Cannabis in Montana
- Cannabis in Nebraska
- Cannabis in Nevada
- Cannabis in New Hampshire
- Cannabis in New Jersey
- Cannabis in New Mexico
- Cannabis in New York
- Cannabis in North Carolina
- Cannabis in North Dakota
- Cannabis in Ohio
- Cannabis in Oklahoma
- Cannabis in Oregon
- Cannabis in Pennsylvania
- Cannabis in Rhode Island
- Cannabis in South Carolina
- Cannabis in South Dakota
- Cannabis in Tennessee
- Cannabis in Texas
- Cannabis in Utah
- Cannabis in Vermont
- Cannabis in Virginia
- Cannabis in Washington
- Cannabis in West Virginia
- Cannabis in Wisconsin
- Cannabis in Wyoming
The National Center for Natural Products Research in Oxford, Mississippi is the only facility in the United States that is federally licensed by the Drug Enforcement Administration to cultivate cannabis for scientific research. The facility is part of the School of Pharmacy at the University of Mississippi, and cultivates cannabis through a contract with the National Institute on Drug Abuse, to which it provides the cannabis.
The federal government has so far refused to grant any other licenses for the cultivation of cannabis, which has had a hindering effect on the amount of research conducted. The cannabis supplied by NIDA has been criticized by researchers for a variety of reasons, including high amounts of stems and seeds, high mold and yeast levels, low THC content, and low diversity of strains available. NIDA has also been criticized for the length of time in which it responds to proposals, and for favoring research on the harms caused by cannabis over research on the health benefits of cannabis. In August 2016, the DEA announced intention to grant additional cultivation licenses, but as of July 2017, 25 applications had been submitted to the DEA and none had been approved, with no timeline given by the DEA for the approval of any licenses.
Research conducted on cannabis also requires licensing from the DEA (specific to Schedule I drugs), and approval from the FDA as well. Prior to 2015, research also required approval from the U.S. Public Health Service, but this requirement was eliminated to make it less difficult for cannabis research to be approved. Numerous medical organizations in the U.S. have called for restrictions on cannabis research to be further eased, including the American Academy of Family Physicians, American Psychological Association, American Cancer Society, American Academy of Pediatrics, and the American Nurses Association.
The great majority of cannabis arrests are for possession. However, in 1997, the vast majority of inmates in state prisons for marijuana-related convictions were convicted of offenses other than simple possession.
According to the Federal Bureau of Investigation's annual Uniform Crime Report, there have been over twelve million cannabis arrests in the United States since 1996, including 749,825 persons for marijuana violations in 2012. Of those charged with marijuana violations in 2012, 658,231 (88%) were charged with possession only. The remaining 91,593 individuals were charged with "sale/manufacture", a category that does not differentiate for cultivation offenses, even those where the marijuana was being grown for personal or medical use. Marijuana arrests comprise almost one-half (48.3 percent) of all drug arrests reported in the United States. According to the American Civil Liberties Union, there were 8.2 million marijuana arrests from 2001 to 2010, and 88% of those arrests were just for having marijuana with them.
The Libertarian Party and the Green Party are known for advocating for the legalization of marijuana. There are also active cannabis political parties in at least five states. These include the Grassroots-Legalize Cannabis Party, the Legal Marijuana Now Party, the Legalize Marijuana Party, and the United States Marijuana Party.
History of cannabis political parties in the U.S.
- The Youth International Party, formed in 1967 to advance the counterculture of the 1960s, often ran candidates for public office. The Yippie flag is a five-pointed star superimposed with a cannabis leaf.
- The Grassroots Party was founded in Minnesota in 1986 and ran numerous candidates for state and federal offices. The party was active in Iowa, Minnesota, and Vermont. Grassroots Party ran candidates in every presidential election from 1988 to 2000.
- The Legal Marijuana Now Party was established in Minnesota in 1998.
- In 1998, an independent candidate, Edward Forchion, ran for Congress from New Jersey as the Legalize Marijuana Party candidate. Since then, Forchion has run several times for a number of offices, under that banner.
- The Marijuana Reform Party was established in New York, in 1998, and ran Gubernatorial candidates there in both 1998 and 2002.
- The United States Marijuana Party is an organization that promotes electoral involvement by marijuana legalization supporters. In 2012, the group endorsed Libertarian Gary Johnson for President.
- The Anti-prohibition Party ran candidates for office in New York State for one election cycle in 2010.
- In 2010 and 2012, independent candidate Cris Ericson was on the ballot for multiple offices in Vermont under the label of U.S. Marijuana.
- The Grassroots political party changed its name in 2014 to Grassroots-Legalize Cannabis Party.
- In 2016, the Legal Marijuana Now Party placed their presidential candidates onto the ballot in two states.
In July 2016, delegates at the 2016 Democratic National Convention voted to approve a party platform calling for cannabis to be removed from the list of Schedule I substances, as well as calling for a "reasoned pathway for future legalization".
Gallup began polling the public as to the issue of legalizing cannabis in 1969; in that year 12% were in favor. The 2017 Gallup poll showed a record high of 64% in favor of legalizing cannabis, including a majority of Republicans for the first time.
According to a 2013 survey by Pew Research Center, a majority of Americans favored complete or partial legalization of cannabis. The survey showed 52% of respondents support cannabis legalization and 45% do not. College graduates' support increased from 39% to 52% in just three years, the support of self-identified conservative Republicans (a group not traditionally supportive of cannabis legalization) had increased to nearly 30%, and bipartisan support had increased across the board. The 2018 version of the poll showed public support had increased to 61%.
Attitudes regarding marijuana regulation changed as some states (Colorado, Washington, Oregon, Maine, and Alaska) have passed their own laws legalizing marijuana for recreational use. According to a Gallup Poll published in December 2012, 64% of Americans believe the federal government should not intervene in these states.
- Adult lifetime cannabis use by country
- Annual cannabis use by country
- Cannabis dispensaries in the United States
- Cannabis political parties
- Legality of cannabis by country
- Legality of cannabis by U.S. jurisdiction
- List of United States politicians who admit to cannabis use
- Minors and the legality of cannabis
- Americans for Safe Access
- Law Enforcement Against Prohibition
- Marijuana Policy Project
- National Organization for the Reform of Marijuana Laws
- National Cannabis Industry Association
- Total Annual Arrests in the US by Year and Type of Offense. Drug War Facts. Page lists FBI Uniform Crime Reports sources. Page links to data table:
- Data table: Total Number of Arrests in the US by Year and Type of Offense. Drug War Facts.
- Drugs and Crime Facts: Drug law violations and enforcement. From the United States Bureau of Justice Statistics (BJS). Source: FBI Uniform Crime Reports. Click on the charts to view the data.
- Marijuana Research: Uniform Crime Reports - Marijuana Arrest Statistics. Has data table for earlier years. Source: FBI Uniform Crime Reports.
- Clarke, Robert; Merlin, Mark (2013). Cannabis: Evolution and Ethnobotany. University of California Press. p. 185. ISBN 978-0-520-95457-1.
- DEA (2013). "The DEA Position on Marijuana" (PDF). Dea.gov. Retrieved May 15, 2016.
- McKinsey, John A.; Burke, Debra (2014). Carper's Understanding the Law. Cengage Learning. p. 216. ISBN 978-1-305-17730-7.
- "State Industrial Hemp Statutes". National Conference of State Legislatures. April 18, 2018. Retrieved July 5, 2018.
- "State Medical Marijuana Laws". National Conference of State Legislatures. June 27, 2018. Retrieved July 5, 2018.
- Frank J. House (2006). Agricultural Programs, Terms and Laws. Nova Publishers. p. 146. ISBN 978-1-59454-892-5.
- White, Rob (2013). Global Environmental Harm: Criminological Perspectives. University of Tasmania. p. 185. ISBN 978-1-134-03031-6.
- Jonathan P. Caulkins; Beau Kilmer; Mark A.R. Kleiman (2016). Marijuana Legalization: What Everyone Needs to Know?. Oxford University Press. p. 25. ISBN 978-0-19-026243-3.
- Lowinson, Joyce H. (2005). Substance Abuse: A Comprehensive Textbook. Lippincott Williams & Wilkins. p. 274. ISBN 978-0-7817-3474-5.
- "Recreational Cannabis in US". Retrieved 5 May 2016.
- David Neubauer; Stephen Meinhold (2013). Judicial Process: Law, Courts, and Politics in the United States. Cengage Learning. p. 108. ISBN 978-1-133-71178-0.
- "Public Health Focus > FDA and Marijuana: Questions and Answers". Fda.gov. Retrieved May 15, 2016.
- Brian F Thomas; Mahmoud ElSohly (2015). The Analytical Chemistry of Cannabis: Quality Assessment, Assurance, and Regulation of Medicinal Marijuana and Cannabinoid Preparations. Elsevier Science. p. 83. ISBN 978-0-12-804670-8.
- Commissioner, Office of the. "Public Health Focus - FDA and Marijuana". www.FDA.gov. Retrieved November 23, 2016.
- Zapotosky, Matt; Horwitz, Sari; Achenbach, Joel (January 4, 2018). "Use of legalized marijuana threatened as Sessions rescinds Obama-era directive that eased federal enforcement". Retrieved January 6, 2018 – via www.WashingtonPost.com.
- Reilly, Ryan J.; Wing, Nick (January 4, 2018). "Jeff Sessions Unleashes Federal Prosecutors On Legal Marijuana". Retrieved January 6, 2018 – via Huff Post.
- The Editors; Roger Roffman; Wayne Hall; Mark A.R. Kleiman; Peter Reuter; Norm Stamper (July 19, 2009). "If Marijuana Is Legal, Will Addiction Rise?". The New York Times. The New York Times Company. Retrieved July 27, 2009.
- Degenhardt, L; Chiu W-T, Sampson N; Kessler, RC; Anthony, JC; et al. (2008). "Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys". PLoS Med. 5 (7): e141. doi:10.1371/journal.pmed.0050141.
- "Results from the 2007 National Survey on Drug Use and Health: National Findings". U.S. Department of Human Health and Services. 2007. Retrieved March 28, 2013.
- SAMHSA, Office of Applied Studies. "2008 Tables: Illicit Drug Use - 1.1 to 1.46 (PE), SAMHSA OAS". Oas.samhsa.gov. Archived from the original on September 4, 2010. Retrieved September 15, 2010.
- NORML / By Paul Armentano (September 10, 2009). "Over 100 Million Americans Have Smoked Marijuana - And It's Still Illegal? | Drugs". AlterNet. Retrieved September 15, 2010.
- Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Percentages, 2010 and 2011?
- "Marijuana as Medicine". National Institute on Drug Abuse.
- "- Retrieved 20 January 2009". Archived from the original on January 20, 2009.
- "Kerlikowske: Legal pot 'not in my vocabulary'". KOMO News. August 7, 2009. Retrieved July 21, 2016.
- "Santa Cruz medical pot collective settles lawsuit with feds - San Jose Mercury News". Mercurynews.com. Retrieved September 15, 2010.
- "Santa Cruz medical pot collective settles lawsuit with feds". Inside Bay Area. Retrieved September 15, 2010.
- "Marijuana Resource Center". Office of National Drug Control Policy.
- "Feds Let Banks and Marijuana Sellers Do Business". Archived from the original on February 14, 2014.
- "The Marijuana Industry's Access to Banks".
- Rough, Lisa (September 14, 2017). "The Cole Memo: What Is It and What Does It Mean?". Leafly. Retrieved January 11, 2018.
- Phelps, Timothy M. "U.S. won't stop Native Americans from growing, selling pot on their lands". Los Angeles Times. Retrieved 12 December 2014.
- Sullum, Jacob (January 4, 2016). "The Federal Ban on Medical Marijuana Was Not Lifted". Reason. Retrieved February 7, 2017.
- Kroll, David. "Senators Introduce Bill To End Federal Curbs On Medical Marijuana". Forbes. Retrieved March 12, 2015.
- Commissioner, Office of the. "Public Health Focus - FDA and Marijuana". www.fda.gov.
- Savage, Charlie; Healy, Jack (January 6, 2018). "Trump Administration Takes Step That Could Threaten Marijuana Legalization Movement". Retrieved January 6, 2018 – via NYTimes.com.
- "Milestones in U.S. Marijuana Laws". The New York Times. Retrieved July 5, 2018.
- "Marijuana Overview". National Conference of State Legislatures. Retrieved July 5, 2018.
- Hudak, John; Wallack, Grace (October 2015), "Ending the U.S. government's war on medical marijuana research" (PDF), Center for Effective Public Management at Brookings, The Brookings Institution
- Gardner, Fred (December 18, 2014). "DEA Upholds Grower's Marijuana Monopoly". CounterPunch. Retrieved January 11, 2018.
- Hellerman, Caleb (March 8, 2017). "Scientists say the government's only pot farm has moldy samples — and no federal testing standards". PBS. Retrieved January 11, 2018.
- The DEA: Four Decades of Impeding And Rejecting Science (PDF), Drug Policy Alliance / Multidisciplinary Associations for Psychedelic Studies, June 2014
- Hudak, John (August 11, 2016). "The DEA's marijuana decision is more important than rescheduling". The Brookings Institution. Retrieved January 11, 2018.
- The Obstruction Of Medical Cannabis Research In The U.S. (PDF), Americans for Safe Access, April 2009
- Staggs, Brooke Edwards (July 2, 2017). "DEA hasn't loosened marijuana cultivation monopoly while applications from researchers mount". The Cannifornian. Retrieved January 11, 2018.
- Zielinski, Alex (August 17, 2016). "The DEA Hasn't Made Marijuana Research Any Easier". ThinkProgress. Retrieved January 11, 2018.
- Nelson, Steven (June 22, 2015). "Major Pot Research Barrier Goes Up in Smoke". U.S. News & World Report. Retrieved January 11, 2018.
- "Marijuana -- AAFP Policies". aafp.org. Retrieved January 11, 2018.
- "Marijuana research: Overcoming the barriers". American Psychological Association. September 14, 2017. Retrieved January 11, 2018.
- "Marijuana and Cancer". American Cancer Society. Retrieved January 11, 2018.
- American Academy of Pediatrics Reaffirms Opposition to Legalizing Marijuana for Recreational or Medical Use, American Academy of Pediatrics, January 26, 2015, retrieved January 11, 2018
- Therapeutic Use of Marijuana and Related Cannabinoids (PDF), American Nurses Association, 2016
- "Drugs and Crime Facts". United States Bureau of Justice Statistics (BJS). Retrieved May 8, 2018..
- "Marijuana". Drug War Facts. Retrieved September 15, 2010.
-  Archived December 3, 2008, at the Wayback Machine.
- "Drug Crimes in the U.S." Fbi.gov.
- "Marijuana Arrests by the Numbers". American Civil Liberties Union.
- Steinberg, Oliver (October 3, 2016). "Third- or even fourth-party candidates can play key roles". Star Tribune.
- Reston, James Jr. (1991). "Collision at Home Plate: The Lives of Pete Rose and Bart Giamatti, p. 78". University of Nebraska Press.
- Minnesota Secretary of State (November 1988). "Minnesota Election Results 1988, p. 18" (PDF). Minnesota Legislative Reference Library.
- Klein, Patricia A. (June 1993). "Federal Elections 92: Election Results for the U.S. President, the U.S. Senate and the U.S. House of Representatives, p. 9" (PDF). Federal Election Commission.
- Bickford, Bob (October 7, 1998). "1996 Presidential Election Results by State". Ballot Access News.
- "2000 Official Presidential General Election Results". Federal Election Commission. December 2001.
- Brash, Jim (April 20, 2016). "Q & A with the Legal Marijuana Now Party of Minnesota". The North Star.
- Worth, Robert (November 7, 2002). "The 2002 Elections: Smaller Parties". The New York Times.
- Winger, Richard (June 15, 2014). "Minnesota Candidate Filing Closes". Ballot Access News.
- Hanson, Alex (August 25, 2016). "Weekly politics wrap-up: Ballot access in Iowa". Iowa State Daily.
- Stassen-Berger, Rachel E. (August 24, 2016). "Don't like Trump or Clinton? You have choices". Pioneer Press.
- Hotakainen, Rob (July 26, 2016). "Democrats become first major party to back pathway to legalizing pot". McClatchy. Retrieved January 11, 2018.
- Smith, Michael. "Support for Legal Marijuana Use Up to 60% in U.S." Gallup. Retrieved 2016-11-20.
- Ingraham, Christopher (October 25, 2017). "For the first time, a majority of Republicans support marijuana legalization". The Washington Post. Retrieved January 11, 2018.
- "Majority Now Supports Legalizing Marijuana". Pew Research Center for the People and the Press. April 4, 2013. Retrieved November 9, 2015.
- Geiger, Abigail (January 5, 2018). "About six-in-ten Americans support marijuana legalization". Pew Research Center. Retrieved January 11, 2018.
- "Americans Want Federal Gov't Out of State Marijuana Laws". Retrieved 2013-04-04.
- Reefer Madness, a 2003 book by Eric Schlosser, detailing the history of marijuana laws in the United States
- The Emperor Wears No Clothes, a 1985 book by Jack Herer